The Global Catheter-Related Bloodstream Infection (CRBSI) Treatment Industry is poised for significant growth, with a projected valuation of US$2,668.6 million by 2033. This represents a robust Compound Annual Growth Rate (CAGR) of 5.6% anticipated during the forecast period (2023-2033). The market’s current strength is evident from its estimated value of US$1,466.9 million in 2022. Although …